Scholar Rock

Develops monoclonal antibodies for serious neuromuscular and metabolic diseases.

BiotechnologyPharmaceuticals scholarrock.com ↗

Company facts

Founded
2012
Employees
324
Headquarters
United States
Type
Public
Listed
NASDAQ: SRRK
Subsidiaries
Scholar Rock, Inc.